Litigation Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2014)
✉ Email this page to a colleague
SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-11-26 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-11-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | Referred To | Mark Falk | |
| Patents | 7,598,271; 8,658,663; 8,946,251 | ||
| Link to Docket | External link to docket | ||
Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL INC. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-11-20 | 137 | assert four patents, U.S. Patent Nos. 5,874,447 (the “447 patent”), 7,598,271 (the “271 patent), 8,658,…,663 (the “663 patent”), and 8,946,251 (the “251 patent”) (collectively, the “patents-in-suit”). …disputed claim terms are found in the ‘271 patent and the ‘251 patent. They are: • Crystalline…the patents-in-suit, as a drug for treating thermoregulatory dysfunction. See, e.g., ‘251 Patent at …methanesulfonate. See, e.g., ‘447 patent 1:27-33. Several of the patent claims at issue relate to different | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
